Results: | |
31 March 2022 | |
31 March 2021 | |
Group revenues | |
T€ | |
31 March 2022 | 164,672 |
31 March 2021 | 133,085 |
R&D expenses | |
T€ | |
31 March 2022 | (18,113) |
31 March 2021 | (18,460) |
Operating result | |
T€ | |
31 March 2022 | 463 |
31 March 2021 | 6,778 |
Adjusted Group EBITDA1) | |
T€ | |
31 March 2022 | 18,862 |
31 March 2021 | 21,105 |
Net income | |
T€ | |
31 March 2022 | (73,242) |
31 March 2021 | 52,702 |
31 March 2022 | |
31 March 2021 | |
Balance sheet data: | |
31 March 2022 | |
31 March 2021 | |
Total stockholders' equity | |
T€ | |
31 March 2022 | 1,309,861 |
31 March 2021 | 793,046 |
Capital expenditure in property, plant and equipment2) | |
T€ | |
31 March 2022 | (42,921) |
31 March 2021 | (36,297) |
Liquidity3) | |
T€ | |
31 March 2022 | 854,816 |
31 March 2021 | 460,556 |
Balance sheet total | |
T€ | |
31 March 2022 | 2,185,023 |
31 March 2021 | 1,580,707 |
Operating cash flow | |
T€ | |
31 March 2022 | 63,618 |
31 March 2021 | 2,459 |
31 March 2022 | |
31 March 2021 | |
Personnel data: | |
31 March 2022 | |
31 March 2021 | |
Employees as of 31 December | |
31 March 2022 | 4,354 |
31 March 2021 | 3,735 |
31 March 2022 | |
31 March 2021 | |
Per share: | |
31 March 2022 | |
31 March 2021 | |
Result (basic/diluted) | |
€ | |
31 March 2022 | (0.41)/(0.41) |
31 March 2021 | 0.32/0.32 |
Multiple-year overview of results of operations and balance sheet as of 31 December 2021
(in €):
Results of operations: | |
20171) | |
20182) | |
20192) | |
20202) | |
2021 | |
Group revenues | |
20171) | 263,765 |
20182) | 375,405 |
20192) | 446,437 |
20202) | 500,925 |
2021 | 618,034 |
Costs of revenue | |
20171) | (181,965) |
20182) | (263,389) |
20192) | (313,546) |
20202) | (375,181) |
2021 | -466,491 |
Gross profit | |
20171) | 81,800 |
20182) | 112,016 |
20192) | 132,891 |
20202) | 125,743 |
2021 | 151,543 |
R&D expenses | |
20171) | (17,614) |
20182) | (35,619) |
20192) | (58,432) |
20202) | (63,945) |
2021 | -72.200 |
SG&A expenses | |
20171) | (42,245) |
20182) | (56,820) |
20192) | (66,433) |
20202) | (77,205) |
2021 | -105.445 |
Impairment of goodwill (net) | |
20171) | - |
20182) | - |
20192) | (1,647) |
20202) | - |
2021 | - |
Impairment of intangible assets (net) | |
20171) | (1,180) |
20182) | (4,364) |
20192) | (10,272) |
20202) | (3,244) |
2021 | -683 |
Income from bargain purchaise | |
20171) | - |
20182) | 15,400 |
20192) | - |
20202) | - |
2021 | - |
Other Operating income (and expenses), net | |
20171) | 16,104 |
20182) | 47,042 |
20192) | 66,600 |
20202) | 67,207 |
2021 | 67,781 |
Operating result | |
20171) | 36,865 |
20182) | 77,655 |
20192) | 62,707 |
20202) | 48,556 |
2021 | 40,996 |
Non-operating income and (expenses), net | |
20171) | (11,162) |
20182) | (5,464) |
20192) | (6,032) |
20202) | (22,716) |
2021 | 195,984 |
Profit (loss) before taxes | |
20171) | 25,703 |
20182) | 71,191 |
20192) | 56,675 |
20202) | 25,840 |
2021 | 236,980 |
Tax income (expense) | |
20171) | (2,383) |
20182) | 12,007 |
20192) | (19,363) |
20202) | (19,562) |
2021 | -21,470 |
Net income | |
20171) | 23,320 |
20182) | 84,198 |
20192) | 37,312 |
20202) | 6,278 |
2021 | 215,510 |
20171) | |
20182) | |
20192) | |
20202) | |
2021 | |
Balance sheet data: | |
20171) | |
20182) | |
20192) | |
20202) | |
2021 | |
Cash, cash equivalents and investments | |
20171) | 91,156 |
20182) | 149,449 |
20192) | 320,022 |
20202) | 481,930 |
2021 | 858,234 |
Trade accounts receivable incl. related parties | |
20171) | 46,113 |
20182) | 48,030 |
20192) | 83,616 |
20202) | 87,896 |
2021 | 134,721 |
Inventories | |
20171) | 5,568 |
20182) | 5,660 |
20192) | 10,749 |
20202) | 13,585 |
2021 | 25,793 |
Deferred tax assets | |
20171) | 18,761 |
20182) | 42,807 |
20192) | 33,779 |
20202) | 24,392 |
2021 | 17,359 |
Property, plant and equipment | |
20171) | 76,069 |
20182) | 90,519 |
20192) | 239,229 |
20202) | 337,297 |
2021 | 484,597 |
Intangible assets, excluding goodwill | |
20171) | 135,033 |
20182) | 122,989 |
20192) | 116,994 |
20202) | 98,036 |
2021 | 30,851 |
Goodwill | |
20171) | 220,447 |
20182) | 220,791 |
20192) | 255,919 |
20202) | 247,370 |
2021 | 257,569 |
Other assets3) | |
20171) | 72,856 |
20182) | 91,116 |
20192) | 120,053 |
20202) | 171,831 |
2021 | 426,037 |
Total assets | |
20171) | 666,003 |
20182) | 771,883 |
20192) | 1,180,361 |
20202) | 1,462,337 |
2021 | 2,235,161 |
Loans and finance leases | |
20171) | 189,928 |
20182) | 114,465 |
20192) | 463,099 |
20202) | 491,965 |
2021 | 512,917 |
Trade accounts payable | |
20171) | 26,078 |
20182) | 31,137 |
20192) | 31,319 |
20202) | 42,549 |
2021 | 72,598 |
Provisions | |
20171) | 37,302 |
20182) | 47,943 |
20192) | 53,553 |
20202) | 62,579 |
2021 | 57,281 |
Contract liabilities | |
20171) | 44,844 |
20182) | 112,228 |
20192) | 104,852 |
20202) | 88,914 |
2021 | 145,537 |
Other liabilities4) | |
20171) | 34,578 |
20182) | 41,208 |
20192) | 48,925 |
20202) | 51,874 |
2021 | 69,143 |
Total stockholders' equity | |
20171) | 333,273 |
20182) | 426,380 |
20192) | 478,613 |
20202) | 724,456 |
2021 | 1,377,685 |
Total liabilities and stockholders' equity | |
20171) | 666,003 |
20182) | 771,361 |
20192) | 1,180,361 |
20202) | 1,462,337 |
2021 | 2,235,161 |
20171) | |
20182) | |
20192) | |
20202) | |
2021 | |
Personnel data: | |
20171) | |
20182) | |
20192) | |
20202) | |
2021 | |
Employees as of 31 December | |
20171) | 2,178 |
20182) | 2,617 |
20192) | 3,030 |
20202) | 3,572 |
2021 | 4,198 |
20171) | |
20182) | |
20192) | |
20202) | |
2021 | |
Per share (in €): |
|
20171) | |
20182) | |
20192) | |
20202) | |
2021 | |
Result (basic/diluted) | |
20171) | 0.16/0.17 |
20182) | 0.56/0.57 |
20192) | 0.25/0.25 |
20202) | 0.04/0.04 |
2021 | 1.30/1.30 |
1) 2017 restated for IFRS 15 and modified by the effect of the finalisation of Aptuit's purchase price allocation in 2018 in accordance with IFRS 3, see Note 4 in the Notes
2) 2018 - 2020 restated for IAS 19
3) Consist of tax receivables, deferred tax assets, contract assets, prepaid expenses, equity investments, other long-term investments and other financial assets
4) Consist of tax receivables, deferred tax assets, contract assets, prepaid expenses, equity investments, other long-term investments and other financial assets
Guidance 2022
€ 105-120 m2)
Group revenues | |
Guidance 2022 | € 700-720 m1) |
Actual 2021 | € 618 m |
Unpartnered R&D expenses | |
Guidance 2022 | € 70-80 m |
Actual 2021 | € 58 m |
Adjusted Group EBITDA3) | |
Guidance 2022 | € 105-120 m2) |
Actual 2021 | € 107 m |
1) At unchanged exchange rates against the average rate for 2021, this forecast range would be approximately € 690 m to € 710 m, ceteris paribus.
2) At unchanged exchange rates against the average rate for 2021, this forecast range would be around € 95 m to € 110 m, ceteris paribus.
3) EBITDA is defined as earnings before interest, taxes, depreciation and amortisation of intangibles. Adjusted EBITDA excludes impairments on goodwill, other intangible and tangible assets, changes in contingent considerations as well as the total non-operating result
Mid-term targets by 2025
≥ € 300 m
Group revenues | |
Mid-term targets by 2025 | > € 1,000 m |
Actual 2021 | € 618.0 m |
Unpartnered R&D expenses | |
Mid-term targets by 2025 | > € 100 m |
Actual 2021 | € 58.1 m |
Adjusted Group EBITDA | |
Mid-term targets by 2025 | ≥ € 300 m |
Actual 2021 | € 107.3 m |